Have a personal or library account? Click to login
Rethinking the Concept of Psychosis and the Link Between Autism and Schizophrenia Cover

Rethinking the Concept of Psychosis and the Link Between Autism and Schizophrenia

By: Bodil Aggernæs  
Open Access
|Nov 2015

References

  1. Craddock N, Owen M. The Kraepelinian dichotomy – going, going …but still not gone. Br J Psychiatry 2010;196:92-95.
  2. Catone G, Pisano S, Broome M, Lindau JF, Pascotto A, Grittu A. Continuity between stressful experiences and delusion content in adolescents with psychotic disorders – a pilot study. Scand J Child Adolesc Psychiatr Psychol 2016;4(1):14-22.
  3. Jaspers K. Allgemeine Psychopathologie. Berlin, Germany:Springer-Verlag;1965.
  4. Mishura AL, Fusar-Poli P. The phenomenology and neurobiology of delusion formation during psychosis onset: Jaspers, Truman symptoms, and aberrant salience. Schizophr Bull 2013;39(2):278-286.
  5. Kapur S, Mizrahi R, Li M. From dopamine to salience to psychosis - linking biology, pharmacology and phenomenology of psychosis. Schizophr Res 2005;79:59-68.
  6. Maher BA. The relationship between delusions and hallucinations. Curr Psychiatry Rep 2006;8(3):179-183.
  7. Garety PA, Freeman D. The past and future of delusions research: from the inexplicable to the treatable. Br J Psychiatry 2013; 203:327-333.
  8. Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington PE. A cognitive model of the positive symptoms of psychosis. Psychol Med 2001;31(2):189-195.
  9. Freeman D, Garety P, Kuipers E, Fowler D, Bebbington P. A cognitive model of persecutory delusions. Br J Psychiatry 2002;41:331-347.
  10. Andersen DB, Vernal DL, Bilenberg N, Væver MS, Stenstrøm AD. Early-onset schizophrenia: Exploring the contribution of the Thought Disorder Index to clinical assessment. Scand J Child Adolesc Psychiatr Psychol 2016;4(1):23-30.
  11. Aggernæs A. The concepts: Disturbed state of consciousness and psychosis. Acta Psychiatr Scand 1975;51:119-133.
  12. Frith U. Autism: Explaining the enigma. Oxford:Blacwell;1989.
  13. Rajendran G, Mitchell P. Cognitive theories of autism. Dev Rev 2007;27:224–60.
  14. Aggernæs A, Haugsted R, Myschetsky H, Paikin H, Vitger J. A reliable clinical technique for investigation of the experienced reality and unreality qualities connected to everyday life experiences in psychotic and non-psychotic persons. Acta Psychiatr Scand 1976;53(4):241-257.
  15. Aggernæs A, Haugsted R. Experienced reality in three to six year-old children: A study of direct reality testing. J Child Psychol Psychiat 1976;17:323-335.
  16. Aggernæs A, Paikin H, Vitger J. Experienced reality in schizophrenia: How diffuse is the defect in reality testing? Indian J Psychol Med 1981;4:1-13.
  17. Piaget J. La psychologie de l’intelligence. Paris :A.Colin;1967.
  18. Torres A, Olivares J, Rodriguez A, Vaamonde A, Berrios G. An analysis of the cognitive deficit of schizophrenia based on the Piaget development theory. Comp Psych 2007;48:376-379.
  19. Nuechterlein KH, Dawson ME, Green MF. Information-processing abnormalities as neuropsychological vulnerability indicators for schizoprenia. Acta Psychiatr Scand Suppl 1994;384:71-79.
  20. Haapasalo-Pesu K-M, Karukivi M, Saarijärvi S. The growing trend of prescribing antipsychotics for young people in Finland, 2000 to 2010. Scand J Child Adolesc Psychiatr Psychol 2016;4(1):31-35.
  21. Gottesman II and Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003;160:636-645.
  22. Kim YS, State MW. Recent challenges to the psychiatric diagnostic nosology: a focus on the genetics and genomics of neurodevelopmental disorders. Int J Epidemiol 2014;43(2):465–75.
  23. Tsuang MT, Owen MJ. Molecular and population genetics of schizophrenia. Neuropsychopharmacology, 5th Generation of Progress 2002:671-687.
  24. Kahn RS, Fleischhacker WW, Boter H, et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 2008;371:1085-1097.
  25. Lieberman JA, Scott Stroup, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2006;353:1209-1223.
  26. Chisholm K, Lin A, Abu-Akel A, Wood SJ. The association between autism and schizophrenia spectrum disorders: A review of eight alternate models of co-occurrence. Neu Bio Rev 2015;55:173-183.
  27. Cox D, Butler M. The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review. Int J Mol Sci 2015;16(2):4068–82.
  28. Elia J, Gai X, Xie HM, et al. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry 2010;15:637–46.
  29. Guilmatre A, Dubourg C, Mosca AL, et al. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry 2009;66:947-956.
  30. Lee SH, Ripke S, Neale BM, et al. (Cross-Disorder Group of the Psychiatric Genomics Consortium). Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 2013; 45(9):984–94.
  31. Moreno-De-Luca D, Mulle JG, Kaminsky EB, et al. Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am J Hum Genet 2010;87(5):618–30.
  32. Rapoport J, Chavez A, Greenstein D, Addington A, Gogtay N. Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited. J Am Acad Child Adolesc Psychiatry 2009;48:10-18.
  33. Smoller JW, Kendler K, Craddock N, et al. (Cross-Disorder Group of the Psychiatric Genomics Consortium). Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013;381:1371–79.
  34. Williams NM, Franke B, Mick E, et al. Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: The role of rare variants and duplications at 15q13.3. Am J Psychiatry 2012;169:195-204.
  35. Banaschewski T, Hollis C, Oosterlaan J, et al. Towards an understanding of unique and shared pathways in the psychopathophysiology of ADHD. Dev Sci 2005;8:132-140.
  36. Braff DL, Freedman R. Endophenotypes in studies of genetics of schizophrenia. Neuropsychopharmacology, 5th Generation of Progress 2002:703-716.
  37. Bredgaard R, Glenthoj BY. Information processing and attentional dysfunctions as vulnerability indicators in schizophrenia spectrum disorders. World J Biol Psychiatry 2000;1:5-15.
  38. Cederlund M, Hagberg B, Gillberg C. Asperger syndrome in adolescent and young adult males Interview, self- and parent assessment of social, emotional, and cognitive problems. Res Dev Disabil 2010;31(2):287-298.
  39. Eack SM, Bahorik AL, McKnight SAF, et al. Commonalities in social and non-social cognitive impairments in adults with autism spectrum disorder and schizophrenia. Schizophr Res 2013;148:24–8.
  40. Greene CM, Braet W, Johnson KA, Bellgrove MA. Imaging the genetics of executive function. Biol Psychol 2008;79:30-42.
  41. Oie M, Rund BR. Neuropsychological deficits in adolescent-onset schizophrenia compared with attention deficit hyperactivity disorder. Am J Psychiatry 1999;156:1216–22.
  42. Simon TJ, Bisch JP, Bearden CE, et al. A multilevel analysis of cognitive dysfunction and psychopathology associated with chromosome 22q11.2 deletion syndrome in children. Dev Psychopathol 2005;17:753-784.
  43. Sugranyes G, Kyriakopoulos M, Corrigall R, Taylor E, Frangou S. Autism spectrum disorders and schizophrenia: meta-analysis of the neural correlates of social cognition. PLoS One 2011;6(10):e25322.
  44. Cochran DM, Dvir Y, Frazier JA. “Autism-plus” spectrum disorders. Child Adolesc Psychiatr Clin N Am. 2013;22(4):609–27.
  45. Rommelse NNJ, Franke B, Geurts HM, Hartman CA, Buitelaar JK. Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. Eur Child Adolesc Psychiatry 2010;19(3):281–95.
  46. Solomon M, Olsen E, Niendam T, et al. From lumping to splitting and back again: atypical social and language development in individuals with clinical-high-risk for psychosis, first episode schizophrenia, and autism spectrum disorders. Schizophr Res 2011;131(1-3):146–51.
  47. Tsuang M. Schizophrenia: genes and environment. Biol Psychiatry 2000;47(3):210–20.
  48. Braff DL, Geyer MA, and Swerdlow NR. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 2001;156:234-258.
  49. Ornitz EM, Russell AT, Gabikian P, Gehricke JG, Guthrie D. Prepulse inhibition of startle, intelligence and familial primary nocturnal enuresis. Acta Paediatr 2000;89:475-481.
  50. Perry W, Minassian A, Lopez B, Maron L, Lincoln A. Sensorimotor gating deficits in adults with autism. Biol Psychiatry 2007;61:482-486.
  51. Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, Swerdlow NR. Neurophysiological endophenotypes of schizophrenia: The viability of selected candidate measures. Schizophr Bull 2007;33:69-94.
  52. Woodberry KA, Giuliano AJ, Seidman LJ. Premorbid IQ in schizophrenia: A meta-analytic review. Am J Psychiatry 2008;165:579–87.
  53. Aukes MF, Alizadeh BZ, Sitskoorn MM, Kemner C, Ophoff RA, Kahn RS. Genetic overlap among intelligence and other candidate endophenotypes for schizophrenia. Biol Psychiatry 2009;65(6):527–34.
  54. Prescott CA, Cross RJ, Kuhn JW, Horn JL, Kendler KS. Is risk for alcoholism mediated by individual differences in drinking motivations? Alcohol Clin Exp Res 2004;28(1):29–39.
  55. Parsons CE, Young KS, Murray L, Stein A, Kringelbach ML. The functional neuroanatomy of the evolving parent-infant relationship. Prog Neurobiol 2010;91:220-241.
  56. Caspi A, Houts RM, Belsky DW, et al. The p factor: One general psychopathology factor in the structure of psychiatric disorders? Clin Psychol Sci 2014;2(2):119–37.
  57. Gillberg C. The ESSENCE in child psychiatry: Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations. Res Dev Dis 2010;31:1543-1551.
  58. Parnas J. A Disappearing Heritage: The Clinical Core of Schizophrenia. Schizophr Bull 2011;37(6):1121–30.
  59. van Os J. A salience dysregulation syndrome. Br J Psychiatry 2009;194(2):101–3.
  60. Reiersen A. Collection of developmental history in the evaluation of schizophrenia spectrum disorders. Scand J Child Adolesc Psychiatr Psychol 2016;4(1):36-43.
Language: English
Page range: 4 - 11
Published on: Nov 30, 2015
Published by: Psychiatric Research Unit
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2015 Bodil Aggernæs, published by Psychiatric Research Unit
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.